Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 3
2006 1
2012 2
2013 11
2014 30
2015 31
2016 36
2017 18
2018 23
2019 22
2020 26
2021 35
2022 26
2023 11
2024 20
2025 17
2026 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

281 results

Results by year

Filters applied: . Clear all
Page 1
Efinaconazole in Onychomycosis.
Gupta AK, Talukder M. Gupta AK, et al. Am J Clin Dermatol. 2022 Mar;23(2):207-218. doi: 10.1007/s40257-021-00660-1. Epub 2021 Dec 13. Am J Clin Dermatol. 2022. PMID: 34902110 Review.
The pharmacokinetic studies suggest that the efinaconazole topical delivery to the nail bed is not markedly affected by the presence of disease. ...The side effects of topical efinaconazole are minimal: most commonly ingrown toenails, dermatitis, vesicles, and pain …
The pharmacokinetic studies suggest that the efinaconazole topical delivery to the nail bed is not markedly affected by the presence …
Efinaconazole.
[No authors listed] [No authors listed] 2018 Dec 3. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2018 Dec 3. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 29999786 Free Books & Documents. Review.
Topical efinaconazole has not been studied during breastfeeding. Because maternal blood levels are very low after topical application to the toenails, it is unlikely that a measurable amount of the drug will enter the breastmilk....
Topical efinaconazole has not been studied during breastfeeding. Because maternal blood levels are very low after topical application …
Efinaconazole topical solution (10%) for the treatment of onychomycosis in adult and pediatric patients.
Vlahovic TC, Gupta AK. Vlahovic TC, et al. Expert Rev Anti Infect Ther. 2022 Jan;20(1):3-15. doi: 10.1080/14787210.2021.1939011. Epub 2021 Jun 30. Expert Rev Anti Infect Ther. 2022. PMID: 34106031 Review.
Overall, efinaconazole is a safe and effective clinical option for the treatment and management of onychomycosis. EXPERT OPINION: Efinaconazole is the first new antifungal approved for onychomycosis in 10 years in the USA. ...
Overall, efinaconazole is a safe and effective clinical option for the treatment and management of onychomycosis. EXPERT OPINION: …
Efinaconazole 10% solution: a comprehensive review of its use in the treatment of onychomycosis.
Gupta AK, Mann A, Polla Ravi S, Wang T, Cooper EA. Gupta AK, et al. Expert Opin Pharmacother. 2024 Oct;25(15):1983-1998. doi: 10.1080/14656566.2024.2416924. Epub 2024 Oct 16. Expert Opin Pharmacother. 2024. PMID: 39394930 Review.
While oral antifungals are first-line for moderate-to-severe onychomycosis, topical efinaconazole 10% solution (JUBLIA ; Clenafin ) is effective and safe for mild-to-moderate severity onychomycosis. ...Efinaconazole may be a consideration when terbinafine resistance …
While oral antifungals are first-line for moderate-to-severe onychomycosis, topical efinaconazole 10% solution (JUBLIA ; Clenafin ) i …
Efinaconazole in the treatment of onychomycosis.
Lipner SR, Scher RK. Lipner SR, et al. Infect Drug Resist. 2015 Jun 1;8:163-72. doi: 10.2147/IDR.S69596. eCollection 2015. Infect Drug Resist. 2015. PMID: 26082652 Free PMC article. Review.
Efinaconazole 10% topical solution is a new triazole recently approved for the treatment of onychomycosis. ...This review summarizes the mechanism of action, in vitro and in vivo data, clinical trials, safety, and quality-of-life data of efinaconazole as it applies …
Efinaconazole 10% topical solution is a new triazole recently approved for the treatment of onychomycosis. ...This review summarizes …
Treating Onychomycosis with Efinaconazole: Considerations for Diverse Patient Groups.
Gupta AK, Taylor D, Dennis D, Wang T, Cooper EA. Gupta AK, et al. J Fungi (Basel). 2025 Nov 28;11(12):843. doi: 10.3390/jof11120843. J Fungi (Basel). 2025. PMID: 41440669 Free PMC article. Review.
Efinaconazole 10% showed similar efficacy in this population, regardless of glycemic control. ...Overall, efinaconazole 10% solution was well-tolerated across patient groups, with application-site reactions occurring without systemic sequalae. ...
Efinaconazole 10% showed similar efficacy in this population, regardless of glycemic control. ...Overall, efinaconazole 10% so …
Efinaconazole and Tavaborole.
Poulakos M, Grace Y, Machin JD, Dorval E. Poulakos M, et al. J Pharm Pract. 2017 Apr;30(2):245-255. doi: 10.1177/0897190016630904. Epub 2016 Jul 8. J Pharm Pract. 2017. PMID: 26873506 Review.
PURPOSE: The purpose of this article is to review the safety, efficacy, and role of efinaconazole and tavaborole in the treatment of onychomycosis. SUMMARY: Onychomycosis is a fungal infection of the nail caused by dermatophytes, yeasts, and nondermatophyte fungi. ...CONCL …
PURPOSE: The purpose of this article is to review the safety, efficacy, and role of efinaconazole and tavaborole in the treatment of …
Efinaconazole 10% solution in the treatment of onychomycosis of the toenails.
Joseph WS, Vlahovic TC, Pillai R, Olin JT. Joseph WS, et al. J Am Podiatr Med Assoc. 2014 Sep-Oct;104(5):479-85. doi: 10.7547/0003-0538-104.5.479. J Am Podiatr Med Assoc. 2014. PMID: 25275736
BACKGROUND: Efinaconazole 10% solution is a new triazole antifungal agent developed for the topical treatment of onychomycosis. ...CONCLUSIONS: The efficacy and safety profile of efinaconazole 10% solution suggests that it may represent an important advance in the t …
BACKGROUND: Efinaconazole 10% solution is a new triazole antifungal agent developed for the topical treatment of onychomycosis. ...CO …
Efinaconazole 10% nail solution: a new topical treatment with broad antifungal activity for onychomycosis monotherapy.
Gupta AK, Paquet M. Gupta AK, et al. J Cutan Med Surg. 2014 May-Jun;18(3):151-5. doi: 10.2310/7750.2013.13095. J Cutan Med Surg. 2014. PMID: 24800702 Review.
BACKGROUND: Topical therapies for onychomycosis are associated with less adverse events than systemic therapies, but poor nail penetration limits their efficacy. Consequently, an efinaconazole 10% nail solution was developed. OBJECTIVE: To review the evidence supporting th …
BACKGROUND: Topical therapies for onychomycosis are associated with less adverse events than systemic therapies, but poor nail penetration l …
281 results